NCT07829705RecruitingPhase 2
Beta-amyloid PET/CT to Measure Potential Therapeutic Response in AL-CA
A Follow-Up Study to Monitor Therapeutic Response in Light Chain Cardiac Amyloidosis Using Beta-amyloid PET/CT
Source: ClinicalTrials.gov · Last updated 21 Sept 2026
Brief summary (registry, in English)
This was a single center, prospective cohort study that is evaluating the ability of beta-amyloid dynamic PET/CT to detect potential therapeutic changes in subjects under treatment for AL-CA after one year had elapsed since their baseline beta-amyloid PET/CT. Demographic, clinical and PET imaging data were collected to characterize potential changes since their baseline scans.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 17 Jun 2026
- Start date
- 3 Jun 2020
- Primary completion date
- 1 Jul 2025
- Lead sponsor
- Peking Union Medical College Hospital
- Diseases
- Amyloidosis
- NCT number
- NCT07829705
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 60
- From 3 Jun 2020 to the primary completion date, 1 Jul 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- received therapy with an approved treatment (e.g., Bortezomib, Daratumumab) prior to enrollment;
Other illness
- any condition deemed by the investigator to interfere with study results or increase participant risk.
Other
- pregnancy or breastfeeding;
- severe claustrophobia;
Who the study is looking for
- Age ≥ 18 y；
- were proven newly diagnosed AL-CA by standard criteria;
- subsequently received first-line therapies including anti-plasma cell therapy or targeted therapy;
- must have given written informed consent (signed and dated) and any authorizations required by local law and be able to comply with all study requirements.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking Union Medical College Hospital Coordinator of this site? Confirm its status | Beijing | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.